N/A
N=159
Tegaderm vs. EyeGard for Eye Protection
Erythema
Bottom Line
View on ClinicalTrials.gov: NCT03549429 ↗Enrolled (actual)
159
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Proportion of Participants With Eyelid Erythema — 117; 105 Participants — p=0.03
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Medical tapes: TegadermTM and EyeGard® (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Tufts Medical Center
- Primary completion
- Jul 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Proportion of Participants With Eyelid Erythema |
117; 105 | 0.03 sig |
| SECONDARY Patient Satisfaction |
4.94; 4.91 | 0.23 |
| SECONDARY Rate of Corneal Abrasions |
0; 0 | — |
Summary
This study compares TegadermTM and EyeGard® in general anesthesia.
Eligibility Criteria
Inclusion Criteria
- Age ≥ 18
- Surgeries scheduled for anesthesia of any duration
Exclusion Criteria
- Any patient that does not consent
- Any patient who has:
- Pre-existing eyelid erythema or other eyelid trauma
- Eyelid piercings
- Any surgery on the head, brain, neck, teeth, mouth, eyes or face
- Surgery in the prone position
- Patients <18 years old
Data sourced from ClinicalTrials.gov (NCT03549429). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.